Abstract

RNA-binding proteins (RBPs) play key roles in post-transcriptional regulation of mRNAs. Dysregulations in RBP-mediated mechanisms have been found to be associated with many steps of cancer initiation and progression. Despite this, previous studies of gene expression in cancer have ignored the effect of RBPs. To this end, we developed a lasso regression model that predicts gene expression in cancer by incorporating RBP-mediated regulation as well as the effects of other well-studied factors such as copy-number variation, DNA methylation, TFs and miRNAs. As a case study, we applied our model to Lung squamous cell carcinoma (LUSC) data as we found that there are several RBPs differentially expressed in LUSC. Including RBP-mediated regulatory effects in addition to the other features significantly increased the Spearman rank correlation between predicted and measured expression of held-out genes. Using a feature selection procedure that accounts for the adaptive search employed by lasso regularization, we identified the candidate regulators in LUSC. Remarkably, several of these candidate regulators are RBPs. Furthermore, majority of the candidate regulators have been previously found to be associated with lung cancer. To investigate the mechanisms that are controlled by these regulators, we predicted their target gene sets based on our model. We validated the target gene sets by comparing against experimentally verified targets. Our results suggest that the future studies of gene expression in cancer must consider the effect of RBP-mediated regulation.

Highlights

  • Aberrant gene expression is a main feature of cancer development

  • We applied our model to Lung squamous cell carcinoma (LUSC) data as we found that there are several RNA-binding proteins (RBPs) differentially expressed in LUSC

  • We applied our model to Lung squamous cell carcinoma (LUSC) dataset, as we found that there are a large number of differentially expressed RBPs in this cancer type

Read more

Summary

Introduction

Aberrant gene expression is a main feature of cancer development. Characterizing the regulatory events that lead to gene expression changes during cancer development is critical for cancer research. Differential gene expression in cancer can occur due to several factors including copy-number variation (CNV), DNA methylation changes, and alterations in transcriptional and post-transcriptional regulatory mechanisms. Among these factors, post-transcriptional regulation (PTR) has gained significant importance due to its emerging roles in cancer biology. PTR is mediated by the interactions of RNA-binding proteins (RBPs) and microRNAs (miRNAs) with target mRNAs through short sequence and/or structure motifs.

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.